Article

172 Transforming the National Genomic Test Directory to Improve Genomic Testing for CNS Tumours

2026-08-27

Abstract excerpt

Abstract Introduction The National Genomic Test Directory (NGTD), introduced in 2019, defines NHS commissioned genomic tests in England and outlines their clinical eligibility. In cancers of the central nervous system (CNS), neuropathologists routinely integrate genomic analysis into diagnostic workflows to support tumour classification and clinical patient management. However, the existing Excel based NGTD is dif...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b8811ba7-c70d-5d5a-8cd3-5c87ff3f37f9
DOI: 10.1093/neuonc/noag172.045

Open publication

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 12 closest

172 Transforming the National Genomic Test Directory to Improve Genomic Testing for CNS TumoursDOI 10.1093/neuonc/noag172.045Read

Whole-Genome Long-Read Sequencing for Rapid Comprehensive Molecular Diagnostics of Brain TumorsSemantic proximity Read

Implementation of an ISO 15189 accredited next generation sequencing service for cell-free total nucleic acid (cfTNA) analysis to facilitate driver mutation reporting in blood: the experience of a clinical diagnostic laboratorySemantic proximity Read

Recommendations for Bioinformatics in Clinical PracticeSemantic proximity Read

Tissue-based next generation sequencing: application in a universal healthcare system.Semantic proximity Read

Quality assurance for next-generation sequencing diagnostics of rare neurological diseases in the European Reference NetworkSemantic proximity Read

Nationwide Genomic Data Analysis of Central Nervous System Tumors in Japan based on C-CAT DatabaseSemantic proximity Read

Nationwide genomic data analysis of central nervous system tumors in Japan based on C-CAT database.Semantic proximity Read

Next generation sequencing in adult patients with glioblastoma in Switzerland: a multi-centre decision analysis.Semantic proximity Read

Protocol for the Tessa Jowell BRAIN MATRIX Platform StudySemantic proximity Read

Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors.Semantic proximity Read

Clinical utility of a blood based assay for the detection of IDH1.R132H-mutant gliomas.Semantic proximity Read

Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnostics.Semantic proximity Read